Navigation Links
China Medicine Wins Best 1000 SME Award in Guangdong Province; Eligible for RMB 25 Million Loan

GUANGZHOU, China, May 15 /PRNewswire-Asia/ -- China Medicine Corporation (OTC Bulletin Board: CHME) (''China Medicine'' or ''the Company''), a leading distributor and developer of prescription and over-the-counter pharmaceuticals, traditional Chinese medicines (''TCM''), nutritional and dietary-supplements, medical devices, and medical formulations in the People's Republic of China (''PRC''), announced today that the Company has received an award for ''Best 1000 Small & Medium Enterprise (SME)'' in Guangdong Province. With this award, the Company is eligible to apply for a RMB 25 million ($3.7 million) loan with zero or minimum interest from the Bank of China, Guangdong branch.

China Medicine was presented the award by the Ministry of Finance in Guangdong Province on May 13, 2009, based on its status as an advanced and innovative Company, and on its reputation and credibility for delivering quality products and services as well as the strength and experience of its management team. Along with the award, the Company is eligible to apply for a one year short-term loan at the principal amount of up to RMB 25 million (approximately US$3,600,000). The interest rate on the loan is based on China's National Benchmark rate. However, 60% of the interest from the loan will be reimbursed by the Ministry of Finance in Guangdong province, and 40% of the interest from the loan will be reimbursed by the local government in Guangdong, provided that the Company is approved for the loan. The Company has started the loan application process and expects to receive the approval in June 2009.

''We are honored to be chosen as one of the best 1000 SME companies in Guangdong Province,'' said Mr. Senshan Yang, Chairman and CEO of China Medicine Corporation. ''With this award, we are entitled to a loan of up to RMB 25 million that will facilitate the financing of our near-term rADTZ commercialization project as well as the launch of other new products in 2009.''

About China Medicine Corporation

China Medicine Corporation is a leading pharmaceutical company that discovers and develops medical formulations and distributes over 2,200 pharmaceutical products in China including prescription and over the counter ("OTC") drugs, traditional Chinese medicine products, herbs and dietary-supplements. The Company distributes its products to wholesale distributors in 28 provinces, more than 300 hospitals, 500 medicine companies, and 1,788 drug stores throughout China. The Company actively develops a number of proprietary products for a variety of uses, including oncology, high blood pressure and the removal of toxins from food and animal feeds. For more information visit the Company's website at .

Cautionary Statement

This press release contains forward-looking statements concerning the Company's business and products. The Company's actual results may differ materially depending on a number of risk factors including, but not limited to, the following: general economic and business conditions, obtaining regulatory approval for new products, the expected contribution of higher margin products, government support for rural health care, competition from existing and new competitors, changes in technology, and various other factors beyond its control. All forward-looking statements are expressly qualified in their entirety by this Cautionary Statement and the risks factors detailed in the Company's reports filed with the Securities and Exchange Commission. China Medicine Corporation undertakes no duty to revise or update any forward- looking statements to reflect events or circumstances after the date of this release.

    For more information, please contact:

    Company Contact:
     Ms. Huizhen Yu
     Chief Financial Officer
     China Medicine Corp
     Tel:   +86-20-8739-1718

    Investor Relations Contact:
     Mr. Crocker Coulson, President
     CCG Investor Relations
     Tel:   +1-646-213-1915 (NY Office)

SOURCE China Medicine Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. China Pharma Holdings, Inc. Reports First Quarter 2009 Financial Results and Corporate Updates
2. China and the Netherlands join forces for research into water management
3. China Sky One Medical, Inc. Announces Record First Quarter 2009 Results
4. China Medicine Announces First Quarter 2009 Results
5. Winner Medical Establishes Joint Venture With West China Hospital in Chengdu, China
6. Jiangbo Pharmaceuticals, Inc. to Present at CCG IRs China Rising Conference in New York
7. China Nepstar Chain Drugstore to Announce First Quarter 2009 Financial Results on Wednesday, May 27, 2009
8. New study reveals the financial effects of stroke in China
9. China Pharma Holdings, Inc. to Report First Quarter 2009 Financial Results on May 15, 2009
10. China Medicine Announces Conference Call to Discuss First Quarter 2009 Results
11. China Medicine to Present at CCG IRs China Rising Conference in New York
Post Your Comments:
(Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from reveals that behind ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology: